North America And Europe Stroke Diagnostics Market Report

North America And Europe Stroke Diagnostics Market Analysis By Technology (Magnetic Resonance Imaging (MRI), Computed Tomography Scan (CT Scan), Carotid Ultrasound, Cerebral Angiography, and Nuclear Imaging), By Region (U.S., Canada, France, Germany, Italy, Spain, and UK) And Segment Forecasts To 2024

Published: July 2016  |  66 Pages  |  Format: PDF  |  Report ID: 978-1-68038-954-8

Industry Insights

The North America and Europe stroke diagnostics market was estimated to be USD 800.0 million in 2015. Stroke is recognized as the world’s second leading cause of death and is responsible for 11.3% of the total deaths around the globe. The U.S. recognizes it as the third leading factor of patient mortality and morbidity, responsible for approximately 140,000 deaths each year.

Stroke cases cost an average of USD 34 billion each year in the U.S.As listed by Centers for Disease Control and Prevention (CDC),the three main types of the disease are hemorrhagic, transient ischemic attack, and ischemic. Ischemic is identified as the most commonly occurring stroke representing 80% of all strokes. Aspects such as high blood pressure (hypertension), smoking, obesity, atrial fibrillation, diabetes, and Fibromuscular Dysplasia (FMD) are the most recognized risk factors that lead to the disease.

Several factors are responsible for causing stroke, but the most commonly occurring factors are the increasing prevalence of unhealthy lifestyle, increasing toll of patients suffering from hypertension, and the escalating aging population. These factors are expected to be the key factors driving the growth of the North America and Europe stroke diagnostics market. Unhealthy lifestyle habits have doubled the risk of the disease among people.

The most notable causes are physical inactivity, increased pressure in work or life, unhealthy diets (leading to obesity), and excessive consumption of alcohol and tobacco. These circumstances are likely to drive demand in the near future. However, the decline in the incidence of the disease rates, pertaining to smoking cessation and better treatment methods, is expected to hinder the growth of the market during the study period.

German Stroke Diagnostics Market, By Technology, 2013 - 2024 (USD Million)

German Stroke Diagnostics Market

Technology Insights

On the basis of technology, the market is fragmented into Magnetic Resonance Imaging (MRI), Computed Tomography Scan (CT Scan), carotid ultrasound, cerebral angiography, nuclear imaging, and others. The computed tomography market, in terms of value, was estimated to account for the largest share in 2015, owing to the increased use of CT scans for diagnosis. CT images are advantageous for their instant acquisition of images and for providing specific and clear information.

On the other hand, technologies such as carotid ultrasound, cerebral angiography, and nuclear imaging are estimated to account for a low share as these technologies are still in the development phase.

Regional Insights

North America is expected to lead the market throughout the forecast period and is anticipated to grow rapidly by 2024. Every year, an approximate of 795,000 people in the U.S. suffers from a stroke and is recognized to cause serious, long-term disability in patients.

The U.S. is projected to witness a significant growth over the forecast period. The African-American population, that represents 13% of the total U.S. population, is reported to be more at risk of the disease. The demand for technologically advanced diagnostic equipment for the purpose of prevention and treatment of stroke is believed to be a major contributing factor to drive the market growth in the U.S.

The European SD imaging market is anticipated to witness a high growth rate. Imaging technologies provide a cost-efficient healthcare alternative and are increasingly used in the modern treatment. A constant shift towards the high performing systems and the increasing use of contrast media are expected to drive the European market in the near future.

Competitive Market Share Insights

Some major players operating in the North America and Europe stroke diagnostics market include Siemens Healthcare, GE Healthcare, and Philips Healthcare. Technological innovations and new product developments are expected to drive the industry growth. For instance, in January 2015, Toshiba Medical Systems Corporation announced the launch of the Toshiba 1.5-tesla MRI system Vantage Titan/cS Edition. Its specialty is cardiac imaging with MRI and it is used for major diagnostic purposes.

Key questions answered by the report
Request for Customization

Choose License Type:

Single User - $4,950
Multi User - $7,950
Enterprise User - $9,950

Special Pricing & Discounts

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA